The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Alterations in high‐density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins
Abstract
Insulin resistance and type 2 diabetes mellitus are generally accompanied by low HDL cholesterol and high plasma triglycerides, which are major cardiovascular risk factors. This review describes abnormalities in HDL metabolism and reverse cholesterol transport, i.e. the transport of cholesterol from peripheral cells back to the liver for metabolism and biliary excretion, in insulin resistance and type 2 diabetes mellitus. Several enzymes including lipoprotein lipase (LPL), hepatic lipase (HL) and lecithin: cholesterol acyltransferase (LCAT), as well as cholesteryl ester transfer protein (CETP) and phospholipid transfer protein (PLTP), participate in HDL metabolism and remodelling. Lipoprotein lipase hydrolyses lipoprotein triglycerides, thus providing lipids for HDL formation. Hepatic lipase reduces HDL particle size by hydrolysing its triglycerides and phospholipids. A decreased postheparin plasma LPL/HL ratio is a determinant of low HDL 2 cholesterol in insulin resistance. The esterification of free cholesterol by LCAT increases HDL particle size. Plasma cholesterol esterification is unaltered or increased in type 2 diabetes mellitus, probably depending on the extent of triglyceride elevation. Subsequent CETP action results in transfer of cholesteryl esters from HDL towards triglyceride‐rich lipoproteins, and is involved in decreasing HDL size. An increased plasma cholesteryl ester transfer is frequently observed in insulin‐resistant conditions, and is considered to be a determinant of low HDL cholesterol. Phospholipid transfer protein generates small pre β‐HDL particles that are initial acceptors of cell‐derived cholesterol. Its activity in plasma is elevated in insulin resistance and type 2 diabetes mellitus in association with high plasma triglycerides and obesity. In insulin resistance, the ability of plasma to promote cellular cholesterol efflux may be maintained consequent to increases in PLTP activity and pre β‐HDL. However, cellular cholesterol efflux to diabetic plasma is probably impaired. Besides, cellular abnormalities that are in part related to impaired actions of ATP binding cassette transporter 1 and scavenger receptor class B type I are likely to result in diminished cellular cholesterol efflux in the diabetic state. Whether hepatic metabolism of HDL‐derived cholesterol and subsequent hepatobiliary transport is altered in insulin resistance and type 2 diabetes mellitus is unknown. Specific CETP inhibitors have been developed that exert major HDL cholesterol‐raising effects in humans and retard atherosclerosis in animals. As an increased CETP‐mediated cholesteryl ester transfer represents a plausible metabolic intermediate between high triglycerides and low HDL cholesterol, studies are warranted to evaluate the effects of these agents in insulin resistance‐ and diabetes‐associated dyslipidaemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,405
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease: The Framingham Study
KANNEL, W. B., CASTELLI, W. P., GORDON, T., & MCNAMARA, P. M. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,057
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Molecular physiology of reverse cholesterol transport.
Fielding, C. J., & Fielding, P. E. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39898-9 · Cited by 1,448
High density lipoprotein metabolism.
Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,210
Plasma cholesteryl ester transfer protein
Tall, A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36957-1 · Cited by 953
Diabetic dyslipidaemia: from basic research to clinical practice*
Taskinen, M.-R. (2003) · Diabetologia · doi:10.1007/s00125-003-1111-y · Cited by 888
Badimon, J. J., Badimon, L., & Fuster, V (1990) · Journal of Clinical Investigation · doi:10.1172/jci114558 · Cited by 764
Navab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C., & Laks, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115532 · Cited by 737
Assmann, G., Schulte, H., von Eckardstein, A., & Huang, Y. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05852-2 · Cited by 698
von Eckardstein, A., Nofer, J.-R., & Assmann, G. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.13 · Cited by 695
Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoprotein
Castro, G. R., & Fielding, C. J. (1988) · Biochemistry · doi:10.1021/bi00401a005 · Cited by 642
Protein-lipid relationships in human plasma
Barr, D. P., Russ, E. M., & Eder, H. A. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90183-0 · Cited by 634
HDL and arteriosclerosis: beyond reverse cholesterol transport
Nofer, J.-R., Kehrel, B., Fobker, M., Levkau, B., Assmann, G., & Eckardstein, A. V. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00651-7 · Cited by 595
Zhong, S., Sharp, D. S., Grove, J. S., Bruce, C., Yano, K., Curb, J. D., & Tall, A. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118751 · Cited by 583
Juhan-Vague, I., Alessi, M. C., & Vague, P. (1991) · Diabetologia · doi:10.1007/bf00403280 · Cited by 567
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
Okamoto, H., Yonemori, F., Wakitani, K., Minowa, T., Maeda, K., & Shinkai, H. (2000) · Nature · doi:10.1038/35018119 · Cited by 531
Cell cholesterol efflux: integration of old and new observations provides new insights
Rothblat, G. H., de la Llera-Moya, M., Atger, V., Kellner-Weibel, G., Williams, D. L., & Phillips, M. C. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32113-1 · Cited by 503
Ectopic β-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis
Martinez, L. O., Jacquet, S., Esteve, J.-P., Rolland, C., Cabezón, E., Champagne, E., Pineau, T., Georgeaud, V., Walker, J. E., Tercé, F., et al. (2003) · Nature · doi:10.1038/nature01250 · Cited by 458
de Grooth, G. J., Kuivenhoven, J. A., Stalenhoef, A. F. H., de Graaf, J., Zwinderman, A. H., Posma, J. L., van Tol, A., & Kastelein, J. J. P. (2002) · Circulation · doi:10.1161/01.cir.0000015857.31889.7b · Cited by 456
A novel endothelial-derived lipase that modulates HDL metabolism
Jaye, M., Lynch, K. J., Krawiec, J., Marchadier, D., Maugeais, C., Doan, K., South, V., Amin, D., Perrone, M., & Rader, D. J. (1999) · Nature Genetics · doi:10.1038/7766 · Cited by 427
Plasma Triglyceride Level and Mortality from Coronary Heart Disease
Criqui, M. H., Heiss, G., Cohn, R., Cowan, L. D., Suchindran, C. M., Bangdiwala, S., Kritchevsky, S., Jacobs, D. R., O'Grady, H. K., & Davis, C. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281702 · Cited by 418
Ordovas, J. M., Cupples, L. A., Corella, D., Otvos, J. D., Osgood, D., Martinez, A., Lahoz, C., Coltell, O., Wilson, P. W. F., & Schaefer, E. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1323 · Cited by 379
Lehto, S., Rönnemaa, T., Haffher, S. M., Pyörälä, K., Kallio, V., & Laakso, M. (1997) · Diabetes · doi:10.2337/diab.46.8.1354 · Cited by 375
The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes
Kuivenhoven, J. A., Pritchard, H., Hill, J., Frohlich, J., Assmann, G., & Kastelein, J. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37433-2 · Cited by 367
Postprandial lipoprotein metabolism and atherosclerosis.
Karpe, F. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00548.x · Cited by 360
Human plasma phospholipid transfer protein causes high density lipoprotein conversion.
Jauhiainen, M., Metso, J., Pahlman, R., Blomqvist, S., van Tol, A., & Ehnholm, C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53575-4 · Cited by 342
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.
Mann, C. J., Yen, F. T., Grant, A. M., & Bihain, B. E. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115535 · Cited by 339
Rittershaus, C. W., Miller, D. P., Thomas, L. J., Picard, M. D., Honan, C. M., Emmett, C. D., Pettey, C. L., Adari, H., Hammond, R. A., Beattie, D. T., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2106 · Cited by 312
Endothelial lipase is a major determinant of HDL level
Ishida, T., Choi, S., Kundu, R. K., Hirata, K.-I., Rubin, E. M., Cooper, A. D., & Quertermous, T. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16306 · Cited by 306
Cloning of a Unique Lipase from Endothelial Cells Extends the Lipase Gene Family
Hirata, K.-I., Dichek, H. L., Cioffi, J. A., Choi, S. Y., Leeper, N. J., Quintana, L., Kronmal, G. S., Cooper, A. D., & Quertermous, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.14170 · Cited by 304
Fumeron, F., Betoulle, D., Luc, G., Behague, I., Ricard, S., Poirier, O., Jemaa, R., Evans, A., Arveiler, D., & Marques-Vidal, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118207 · Cited by 301
Pykälistö, O. J., Smith, P. H., & Brunzell, J. D. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108185 · Cited by 285
Eisenberg, S., Gavish, D., Oschry, Y., Fainaru, M., & Deckelbaum, R. J. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111444 · Cited by 284
Hirano, K.-I., Yamashita, S., Nakajima, N., Arai, T., Maruyama, T., Yoshida, Y., Ishigami, M., Sakai, N., Kameda-Takemura, K., & Matsuzawa, Y. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1053 · Cited by 275
Remodelling of high density lipoproteins by plasma factors
Rye, K.-A., Clay, M. A., & Barter, P. J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00150-1 · Cited by 273
Agerholm-Larsen, B., Nordestgaard, B. G., Steffensen, R., Jensen, G., & Tybjærg-Hansen, A. (2000) · Circulation · doi:10.1161/01.cir.101.16.1907 · Cited by 267
Guérin, M., Le Goff, W., Lassel, T. S., Van Tol, A., Steiner, G., & Chapman, M. J. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.2.282 · Cited by 258
Effects of Diabetes Mellitus on Cholesterol Metabolism in Man
Bennion, L. J., & Grundy, S. M. (1977) · New England Journal of Medicine · doi:10.1056/nejm197706162962401 · Cited by 253
Sugano, M., Makino, N., Sawada, S., Otsuka, S., Watanabe, M., Okamoto, H., Kamada, M., & Mizushima, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5033 · Cited by 241
Preiss-Landl, K., Zimmermann, R., Hämmerle, G., & Zechner, R. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00002 · Cited by 240
Guerin, M., Lassel, T. S., Le Goff, W., Farnier, M., & Chapman, M. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.1.189 · Cited by 237
Insulin Resistance Implications for Type II Diabetes Mellitus and Coronary Heart Disease
Haffner, S. M., & Miettinen, H. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00027-2 · Cited by 229
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men
Lamarche, B., Uffelman, K. D., Carpentier, A., Cohn, J. S., Steiner, G., Barrett, P. H., & Lewis, G. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5286 · Cited by 229
Wang, Y., & Oram, J. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109977200 · Cited by 225
Silver, D. L., Wang, N., Xiao, X., & Tall, A. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101726200 · Cited by 223
Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit
Miller, N. E., Ville, A. L., & Crook, D. (1985) · Nature · doi:10.1038/314109a0 · Cited by 206
The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism
Trigatti, B., Rigotti, A., & Krieger, M. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200004000-00004 · Cited by 206
de la Llera Moya, M., Atger, V, Paul, J. L., Fournier, N., Moatti, N., Giral, P., Friday, K. E., & Rothblat, G. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1056 · Cited by 205
Structure, function and regulation of the ABC1 gene product
Schmitz, G., & Langmann, T. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00006 · Cited by 203
Murakami, T., Michelagnoli, S., Longhi, R., Gianfranceschi, G., Pazzucconi, F., Calabresi, L., Sirtori, C. R., & Franceschini, G. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1819 · Cited by 201
High density lipoprotein conversion mediated by human plasma phospholipid transfer protein.
Tu, A. Y., Nishida, H. I., & Nishida, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49431-3 · Cited by 199
Fielding, C. J., & Fielding, P. E. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3911 · Cited by 196
DULLAART, R. P. F., SLUITER, W. J., DIKKESCHEI, L. D., HOOGENBERG, K., & TOL, A. V. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb00987.x · Cited by 195
Self-citationGuérin, M., Bruckert, E., Dolphin, P. J., Turpin, G., & Chapman, M. J. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.6.763 · Cited by 195
Hepatic lipase:structure/function relationship, synthesis,and regulation
Perret, B., Mabile, L., Martinez, L., Tercé, F., Barbaras, R., & Collet, X. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r100020-jlr200 · Cited by 195
Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol.
Hannuksela, M., Marcel, Y., Kesäniemi, Y., & Savolainen, M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41437-3 · Cited by 192
Transport of Bile Acids in Hepatic and Non-Hepatic Tissues
St-Pierre, M. V., Kullak-Ublick, G. A., Hagenbuch, B., & Meier, P. J. (2001) · Journal of Experimental Biology · doi:10.1242/jeb.204.10.1673 · Cited by 186
Molecular mechanisms of reverse cholesterol transport
Barter, P. J., & Rye, K.-A. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199604000-00006 · Cited by 181
Complete cDNA encoding human phospholipid transfer protein from human endothelial cells.
Day, J. R., Albers, J. J., Lofton-Day, C. E., Gilbert, T. L., Ching, A. F., Grant, F. J., O'Hara, P. J., Marcovina, S. M., & Adolphson, J. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37120-x · Cited by 176
Ohgami, N., Nagai, R., Miyazaki, A., Ikemoto, M., Arai, H., Horiuchi, S., & Nakayama, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011613200 · Cited by 176
Phospholipid transfer protein mediated conversion of high density lipoproteins generates preβ1-HDL
von Eckardstein, A., Jauhiainen, M., Huang, Y., Metso, J., Langer, C., Pussinen, P., Wu, S., Ehnholm, C., & Assmann, G. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00050-1 · Cited by 171
Dachet, C., Poirier, O., Cambien, F., Chapman, J., & Rouis, M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.507 · Cited by 168
Nonenzymatic Glycosylation of HDL and Impaired HDL-Receptor–Mediated Cholesterol Efflux
Duell, P. B., Oram, J. F., & Bierman, E. L. (1991) · Diabetes · doi:10.2337/diab.40.3.377 · Cited by 164
Apolipoprotein A-II, HDL metabolism and atherosclerosis
Tailleux, A., Duriez, P., Fruchart, J., & Barthelemy-Clavey, V. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00751-1 · Cited by 163
Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma.
Groener, J. E., Pelton, R. W., & Kostner, G. M. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.2.283 · Cited by 162
Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL
Groen, A. K., Bloks, V. W., Bandsma, R. H. J., Ottenhoff, R., Chimini, G., & Kuipers, F. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12473 · Cited by 162
Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease
Boekholdt, S. M., & Thompson, J. F. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r200018-jlr200 · Cited by 162
Dynamics of reverse cholesterol transport: protection against atherosclerosis
Sviridov, D., & Nestel, P. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00677-3 · Cited by 161
Forcheron, F., Cachefo, A., Thevenon, S., Pinteur, C., & Beylot, M. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3486 · Cited by 158
Damen, J., Regts, J., & Scherphof, G. L. (1982) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(82)90271-5 · Cited by 155
Blanco‐Vaca, F., Escolá‐Gil, J. C., Martín-Campos, J. M., & Julve, J. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31499-1 · Cited by 150
Speijer, H., Groener, J. E. M., VANRAMSHORST, E., & Vantol, A. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90110-o · Cited by 149
Durrington, P. N., Mackness, M., Bhatnagar, D., Julier, K., Prais, H., Arrol, S., Morgan, J., & Wood, G. N. I. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00003-3 · Cited by 145
Uehara, Y., Engel, T., Li, Z., Goepfert, C., Rust, S., Zhou, X., Langer, C., Schachtrup, C., Wiekowski, J., Lorkowski, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2922 · Cited by 139
Hannuksela, M. L., Liinamaa, J., Kesäniemi, Y. A., & Savolainen, M. J. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90065-5 · Cited by 138
Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity.
Pollare, T., Vessby, B., & Lithell, H. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1192 · Cited by 138
Panarotto, D., Rémillard, P., Bouffard, L., & Maheux, P. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00945.x · Cited by 137
Radioimmunoassay of human plasma lecithin-cholesterol acyltransferase.
Albers, J. J., Adolphson, J. L., & Chen, C. H. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110006 · Cited by 137
Ishida, B. Y., Frolich, J., & Fielding, C. J. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38645-4 · Cited by 136
Gautier, T., Masson, D., de Barros, J.-P. P., Athias, A., Gambert, P., Aunis, D., Metz‐Boutigue, M., & Lagrost, L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007210200 · Cited by 135
Riemens, S. C., van Tol, A., Sluiter, W. J., & Dullaart, R. P. F. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00111-7 · Cited by 133
Self-citationMero, N., Malmström, R., Steiner, G. A., Taskinen, M., & Syvänne, M. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00364-0 · Cited by 131
Agerholm-Larsen, B., Tybjærg‐Hansen, A., Schnohr, P., Steffensen, R., & Nordestgaard, B. G. (2000) · Circulation · doi:10.1161/01.cir.102.18.2197 · Cited by 130
Whitlock, M. E., Swenson, T. L., Ramakrishnan, R., Leonard, M., Marcel, Y. L., Milne, R. W., & Tall, A. R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114132 · Cited by 126
Herrera, V. L. M., Makrides, S. C., Xie, H. X., Adari, H. Y., Krauss, R. M., Ryan, U. S., & Ruiz‐Opazo, N. (1999) · Nature Medicine · doi:10.1038/70956 · Cited by 120
Taskinen, M. (1990) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80078-3 · Cited by 116
Watts, G. F., & Playford, D. A. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00170-1 · Cited by 114
Scavenger Receptors that Recognize Advanced Glycation End Products
Miyazaki, A. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00171-8 · Cited by 113
Lahdenper, S., Syv�nne, M., Kahri, J., & Taskinen, M. (1996) · Diabetologia · doi:10.1007/bf00400677 · Cited by 110
Syvänne, M., Castro, G., Dengremont, C., Geitere, C. D., Jauhiainen, M., Ehnholm, C., Michelagnoli, S., Franceschini, G., Kahri, J., & Taskinen, M. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05962-x · Cited by 107
Riemens, S. C., van Tol, A., Sluiter, W. J., & Dullaart, R. P. F. (1998) · Diabetologia · doi:10.1007/s001250051009 · Cited by 107
Self-citationAccelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus
Bagdade, J. D., Lane, J. D., Subbaiah, P. V., OTTO, M., & Ritter, M. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90177-v · Cited by 106
van Venrooij, F. V., Stolk, R. P., Banga, J.-D., Sijmonsma, T., van Tol, A., Erkelens, D. W., Dallinga‐Thie, G. M., & for the DALI study group (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1216 · Cited by 102
The Role of Insulin Insensitivity and Hepatic Lipase in the Dyslipidaemia of Type 2 Diabetes
Baynes, C., Henderson, A. D., Anyaoku, V., Richmond, W., Hughes, C. L., Johnston, D. G., & Elkeles, R. S. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01652.x · Cited by 100
Jin, W., Marchadier, D. H. L., & Rader, D. J. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00589-1 · Cited by 99
Syvänne, M., Hilden, H., & Taskinen, M. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40121-x · Cited by 97
Kauma, H., Savolainen, M. J., Heikkilä, R., Rantala, A. O., Lilja, M., Reunanen, A., & Kesäniemi, Y. A. (1996) · Human Genetics · doi:10.1007/bf02265258 · Cited by 95
Rye, K., Jauhiainen, M., Barter, P. J., & Ehnholm, C. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33299-5 · Cited by 95
Tall, A. R., Sammett, D., Vita, G., Deckelbaum, R. J., & Olivecrona, T. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42741-4 · Cited by 94
Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics
Laakso, M., Voutilainen, E., Sarlund, H., Aro, A., Pyörälä, K., & Penttilä, I. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90003-6 · Cited by 91
Wang, X., Driscoll, D. M., & Morton, R. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1814 · Cited by 90
Kärkkäinen, M., Oka, T., Olkkonen, V. M., Metso, J., Hattori, H., Jauhiainen, M., & Ehnholm, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112247200 · Cited by 87
Changes of lipolytic enzymes cluster with insulin resistance syndrome
Knudsen, P., Eriksson, J., Lahdenper, S., Kahri, J., Groop, L., Taskinen, M., & The Botnia Study Group (1995) · Diabetologia · doi:10.1007/bf00400640 · Cited by 87
Howard, B. V., Abbott, W. G. H., Beltz, W. F., Harper, I. T., Fields, R. M., Grundy, S. M., & Taskinen, M. (1987) · Metabolism · doi:10.1016/0026-0495(87)90096-5 · Cited by 87
Nishida, H. I., & Nishida, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6959 · Cited by 86
Brites, F. D., Bonavita, C. D., Geitere, C. D., Cloës, M., Delfly, B., Yael, M. J., Fruchart, J., Wikinski, R., & Castro, G. R. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00452-9 · Cited by 83
Kuivenhoven, J. A., Groenemeyer, B. E., Boer, J. M. A., Reymer, P. W. A., Berghuis, R., Bruin, T., Jansen, H., Seidell, J. C., & Kastelein, J. J. P. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.3.595 · Cited by 77
Dyslipidemia in Non-Insulin-Dependent Diabetes Mellitus
Howard, B. V., & Howard, W. J. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-263 · Cited by 76
Desrumaux, C. M., Athias, A., Bessède, G., Vergès, B. L., Farnier, M., Perségol, L., Gambert, P., & Lagrost, L. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.2.266 · Cited by 76
Le, N., Innis‐Whitehouse, W., Li, X., Bakker-Arkema, R. G., Black, D. M., & Brown, W. V. (2000) · Metabolism · doi:10.1016/s0026-0495(00)91169-7 · Cited by 75
Channon, K. M., Clegg, R. J., Bhatnagar, D., Ishola, M., Arrol, S., & Durrington, P. N. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90029-i · Cited by 71
Guérin, M., Dolphin, P. J., Talussot, C., Gardette, J., Berthézène, F., & Chapman, M. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1359 · Cited by 70
Cholesteryl ester transfer protein and its plasma regulator
Morton, R. E. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199908000-00006 · Cited by 70
Post, S. M., de Crom, R., van Haperen, R., van Tol, A., & Princen, H. M. G. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000067702.22390.20 · Cited by 69
Vassiliou, G., Benoist, F., Lau, P., Kavaslar, G. N., & McPherson, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103954200 · Cited by 68
Linkage of the Cholesteryl Ester Transfer Protein ( CETP ) Gene to LDL Particle Size
Talmud, P. J., Edwards, K. L., Turner, C. M., Newman, B. M., Palmen, J., Humphries, S. E., & Austin, M. A. (2000) · Circulation · doi:10.1161/01.cir.101.21.2461 · Cited by 68
High Density Lipoproteins (HDL) and the Oxidative Hypothesis of Atherosclerosis
Bonnefont‐Rousselot, D., Thérond, P., Beaudeux, J., Peynet, J., Legrand, A., & Delattre, J. (1999) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1999.139 · Cited by 68
Downregulation of High-Density Lipoprotein Receptor in Human Fibroblasts by Insulin and IGF-I
Oppenheimer, M. J., Sundquist, K., & Bierman, E. L. (1989) · Diabetes · doi:10.2337/diab.38.1.117 · Cited by 67
Influence of obesity and insulin sensitivity on phospholipid transfer protein activity
Kaser, S., Sandhofer, A., Föger, B., Ebenbichler, C. F., Igelseder, B., Malaimare, L., Paulweber, B., & Patsch, J. R. (2001) · Diabetologia · doi:10.1007/s001250100630 · Cited by 66
Huuskonen, J., Ekström, M., Tahvanainen, E., Vainio, A., Metso, J., Pussinen, P. J., Ehnholm, C., Olkkonen, V. M., & Jauhiainen, M. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00429-3 · Cited by 66
Bultel-Brienne, S., Lestavel, S., Pilon, A., Laffont-Proust, I., Tailleux, A., Fruchart, J., Siest, G., & Barthelemy-Clavey, V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201943200 · Cited by 63
Zhang, Z., Yamashita, S., Hirano, K., Nakagawa-Toyama, Y., Matsuyama, A., Nishida, M., Sakai, N., Fukasawa, M., Arai, H., Miyagawa, J., et al. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00490-7 · Cited by 62
Postprandial Lipoprotein Metabolism
Sethi, S. K., Gibney, M. J., & Williams, C. M. (1993) · Nutrition Research Reviews · doi:10.1079/nrr19930011 · Cited by 62
Murdoch, S. J., Carr, M. C., Hokanson, J. E., Brunzell, J. D., & Albers, J. J. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32057-5 · Cited by 62
Riemens, S. C., van Tol, A., Sluiter, W. J., & Dullaart, R. P. F. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1631 · Cited by 59
Self-citationCombined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL.
Lagrost, L., Gambert, P., & Lallemant, C. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.8.1327 · Cited by 59
Reverse cholesterol transport in diabetes mellitus
Quintão, E. C. R., Medina, W. L., & Passarelli, M. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200007/08)16:4<237::aid-dmrr127>3.0.co;2-9 · Cited by 57
Temel, R. E., Walzem, R. L., Banka, C. L., & Williams, D. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203014200 · Cited by 56
Ahnadi, C.-E., Berthézène, F., & Ponsin, G. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90024-o · Cited by 54
Goto, A., Sasai, K., Suzuki, S., Fukutomi, T., Ito, S., Matsushita, T., Okamoto, M., Suzuki, T., Itoh, M., Okumura‐Noji, K., et al. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00476-2 · Cited by 52
Arii, K., Suehiro, T., Yamamoto, M., Ito, H., & Hashimoto, K. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90211-0 · Cited by 49
Dullaart, R. P. F., de Vries, R., Scheek, L. M., Borggreve, S. E., van Tol, A., Dallinga‐Thie, G. M., Ito, M., Nagano, M., Sluiter, W. J., Hattori, H., et al. (2004) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510410005721 · Cited by 49
Self-citationFournier, N., Atger, V., Cogny, A., Vedie, B., Giral, P., Simon, A. C., MOATTI, N., & Paul, J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00730-9 · Cited by 49
Cholesteryl ester transfer protein, high density lipoprotein and arterial disease
Barter, P. J., & Rye, K. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200108000-00002 · Cited by 48
Riemens, S. C., van Tol, A., Stulp, B. K., & Dullaart, R. P. F. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33389-7 · Cited by 47
Self-citationLottenberg, S. A., Lottenberg, A. M., Nunes, V. S., McPherson, R., & Quintão, E. C. R. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05938-2 · Cited by 43
Kobayashi, J., Okamoto, H., OTABE, M., Bujo, H., & Saitō, Y. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00705-5 · Cited by 41
Riemens, S. C., van Tol, A., Sluiter, W. J., & Dullaart, R. P. F. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33388-5 · Cited by 40
Self-citationFournier, N., Cogny, A., Atger, V., Pastier, D., Goudounèche, D., Nicoletti, A., MOATTI, N., Chambaz, J., Paul, J., & Kalopissis, A. D. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000013023.11297.b2 · Cited by 38
Durlach, V., Attia, N., Zahouani, A., Leuténegger, M., & Girard-Globa, A. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05697-1 · Cited by 38
Kothari, H. V., Poirier, K., Lee, W. H., & Satoh, Y. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)05981-3 · Cited by 37
Bruggen, D. V.-V., Kalkman, I., van Gent, T., van Tol, A., & Jansen, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32038 · Cited by 37
Cheung, M. C., Knopp, R. H., Retzlaff, B. M., Kennedy, H., Wolfbauer, G., & Albers, J. J. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00054-6 · Cited by 36
Dullaart, Riemens, Scheek, & van Tol, A. (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00521.x · Cited by 36
Olefsky, J. M. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80146-7 · Cited by 35
MOWRI, H.-O., Patsch, J. R., Ritsch, A., Föger, B., Brown, S., & Patsch, W. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41218-0 · Cited by 35
Low density lipoprotein (LDL) binding affinity for the LDL receptor in hyperlipoproteinemia
Toyota, Y., Yamamura, T., Miyake, Y., & Yamamoto, A. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00166-5 · Cited by 34
Homma, Y., Ozawa, H., Kobayashi, T., Yamaguchi, H., Sakane, H., Mikamia, Y., Mikami, Y., & Nakamura, H. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90124-4 · Cited by 34
Medh, J. D., Fry, G. L., Bowen, S. L., Ruben, S., Wong, H., & Chappell, D. A. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31980-5 · Cited by 34
Bhatnagar, D., Durrington, P. N., Kumar, S., Mackness, M., & Boulton, A. J. M. (1996) · Diabetic Medicine · Cited by 34
Franceschini, G., Lovati, M. R., Manzoni, C., Michelagnoli, S., Pazzucconi, F., Gianfranceschi, G., Vecchio, G., & Sirtori, C. R. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05465-u · Cited by 33
Passarelli, M., Shimabukuro, A. F. M., Catanozi, S., Nakandakare, E. R., Rocha, J. C., Carrilho, A. J. F., & Quintão, E. C. R. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00336-3 · Cited by 33
Brites, F. D., Cavallero, E., Geitere, C. D., Nicolaı̈ew, N., JACOTOT, B., Rosseneu, M., Fruchart, J., Wikinski, R. L. W., & Castro, G. R. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(98)00155-7 · Cited by 29
Jones, R. J., Owens, D., Brennan, C., Collins, P. B., Johnson, A. H., & Tomkin, G. H. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05639-4 · Cited by 29
Delineation of the Role of Pre-β 1 -HDL in Cholesterol Efflux Using Isolated Pre-β 1 -HDL
Sviridov, D., Miyazaki, O., Theodore, K., Hoang, A., Fukamachi, I., & Nestel, P. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000029120.44088.fe · Cited by 29
Pastier, D., Dugué, S., Boisfer, E., Atger, V., Quang, N. T., van Tol, A., Chapman, M. J., Chambaz, J., Laplaud, P. M., & Kalopissis, A. D. (2001) · Biochemistry · doi:10.1021/bi010348m · Cited by 28
van Tol, A. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510151067866 · Cited by 28
Rinninger, F., Brundert, M., Budzinski, R.-M., Fruchart, J., Greten, H., & Castro, G. R. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00311-8 · Cited by 27
Effect of gemfibrozil on the regulation of HDL subfractions in hypertriglyceridaemic patients
Kahri, J., Sane, T., van Tol, A., & Taskinen, M. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01220.x · Cited by 27
Stender, S., & Hjelms, E. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111606 · Cited by 27
Ahnadi, C.-E., Masmoudi, T., Berthezène, F., & Ponsin, G. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00791.x · Cited by 26
van Tol, A. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510151068027 · Cited by 25
Dullaart, R. P. F., & van Tol, A. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00691-2 · Cited by 23
Self-citationNon-insulin dependent diabetes and reverse cholesterol transport
Berthézène, F. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05855-8 · Cited by 16
LDL receptor-independent and -dependent uptake of lipoproteins
van Berkel, T. J. C., Fluiter, K., van Velzen, A. G., Vogelezang, C. J., & Ziere, G. J. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05731-5 · Cited by 15
HDL subparticles and coronary artery disease in NIDDM
O’Brien, T., Nguyen, T. T., Hallaway, B. J., Hodge, D. O., Bailey, K. R., & Kottke, B. A. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05744-7 · Cited by 14
Boucher, P., Ducluzeau, P., Davelu, P., Andréelli, F., Vallier, P., Riou, J. P., Laville, M., & Vidal, H. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00169-2 · Cited by 11
6 Enzymes involved in plasma cholesterol transport
Barter, P. J., Hopkins, G. J., & Rajaram, O. V. (1987) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(87)80026-5 · Cited by 9
Dullaart, R. P. F., & van Tol, A. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00507.x · Cited by 7
Self-citation
Cited by
Dyslipidemia in type 2 diabetes mellitus
Mooradian, A. D. (2009) · Nature Reviews Endocrinology · doi:10.1038/ncpendmet1066 · Cited by 1,042
Cardiovascular Effects and Benefits of Exercise
Nystoriak, M. A., & Bhatnagar, A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00135 · Cited by 833
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Cardiology · doi:10.1159/000346463 · Cited by 748
Kontush, A., & Chapman, M. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.1 · Cited by 647
Hepatic insulin resistance, metabolic syndrome and cardiovascular disease
Meshkani, R., & Adeli, K. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.05.018 · Cited by 458
Metadata
- Authors
- Borggreve, S. E., De Vries, R., & Dullaart, R. P. F.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2003-11-25
- Volume
- 33
- Issue
- 12
- Pages
- 1051-1069
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W2007342896
- Cited by
- 278
- References
- 174
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.